本页面由Tiger Trade Technology Pte. Ltd.提供服务

Cytokinetics

62.79
-0.1200-0.19%
盘后:62.790.00000.00%16:10 EDT
成交量:125.39万
成交额:7,884.64万
市值:87.29亿
市盈率:-8.74
高:63.50
开:62.48
低:62.13
收:62.91
52周最高:88.31
52周最低:54.30
股本:1.39亿
流通股本:1.38亿
量比:0.50
换手率:0.91%
股息:- -
股息率:- -
每股收益(TTM):-7.1827
每股收益(LYR):-6.5400
净资产收益率:-572.15%
总资产收益率:-28.09%
市净率:-50.32
市盈率(LYR):-9.60

数据加载中...

2026/05/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/05

重要事件披露

Form 8-K - Current report
2026/05/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/05

重要事件披露

Form 8-K - Current report
2026/04/29

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/26

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/24

重要事件披露

Form 8-K - Current report
2026/02/17

重要事件披露

Form 8-K - Current report
2026/01/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities